Pfizer wants to party with docs online

Pfizer is crashing an online party for physicians. The drug maker has inked a deal with Sermo, a sort of Facebook for docs who want to gossip about their practices--drug side effects included. Originally intended to be a "no pharma" zone where doctors could be frank about drugs, the site now will allow Pfizer medical staff to listen in on postings and contribute to the conversation, too. The rest of Pfizer's employees would be persona non grata.

Sermo officials said members recently expressed a wish for input from the pharma industry. And Pfizer wants to tap into the online-networking zeal that has made MySpace a cultural touchstone. Though Pfizer is the first drug maker to get into this "in crowd," it won't be the last; Sermo says it's working on similar deals with other companies. But the site still won't let pharma firms advertise.

- see the release from Sermo
- check out this Boston Channel article
- read about possible effects on industry communication with doctors

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.